Fidelity Disruptive Medicine ETF (FMED)

Assets	$63.28M
Expense Ratio	0.50%
PE Ratio	45.65
Shares Out	2.32M
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a

Volume	3,796
Open	26.84
Previous Close	26.98
Day's Range	26.57 - 27.04
52-Week Low	20.69
52-Week High	29.07
Beta	1.00
Holdings	70
Inception Date	Apr 16, 2020

About FMED

Fund Home Page

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is issued by Fidelity.

• Asset Class: Equity
• Category: Health
• Stock Exchange: NASDAQ
• Ticker Symbol: FMED
• ETF Provider: Fidelity

Top 10 Holdings

40.42% of assets

Name	Symbol	Weight
Fidelity Securities Lending Cash Central Fund	n/a	6.89%
Boston Scientific Corporation	BSX	4.70%
Danaher Corporation	DHR	4.29%
argenx SE	ARGX	4.12%
UCB SA	UCB	4.00%
Cogent Biosciences, Inc.	COGT	3.60%
Penumbra, Inc.	PEN	3.39%
Alnylam Pharmaceuticals, Inc.	ALNY	3.35%
Veeva Systems Inc.	VEEV	3.34%
Intuitive Surgical, Inc.	ISRG	2.75%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 20, 2024	$0.112	Dec 24, 2024
Jun 21, 2024	$0.001	Jun 25, 2024

Performance

FMED had a total return of 1.67% in the past year, including dividends. Since the fund's inception, the average annual return has been 2.48%.